Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TREASURIES-Yields take a breather ahead of presidential debate

Mon, 28th Sep 2020 20:34

(New throughout, updates prices, market activity and comments)

By Kate Duguid

NEW YORK, Sept 28 (Reuters) - U.S. Treasury yields were
roughly flat toward the end of a quiet Monday, with no
significant data releases or Treasury issuance on the calendar,
and investors holding off from making significant moves ahead of
Tuesday's presidential debate.

The benchmark 10-year yield was up 0.2 basis
point on the day at 0.661%, with the 30-year yield
last up 1.6 basis points at 1.421%. The two-year yield
was unchanged on the day at 0.131%.

"Today the price action is modest, which is what you would
expect. There is a very quiet data calendar and no supply to
speak of. To me, the most important risk for markets in the next
five-six weeks is the presidential election, followed closely by
a second wave of COVID," said Jon Hill, U.S. rates strategist at
BMO Capital Markets.

The first debate between the two candidates for the U.S.
presidency – incumbent Republican Donald Trump and former Vice
President Joe Biden, a Democrat – is scheduled for Tuesday
evening.

With five weeks to go until the Nov. 3 general election, the
stakes are high. Trump has recently refused to commit to a
peaceful transfer of power if he loses the election to Biden,
and has said he expects the Supreme Court will have to declare a
winner.

"For better or worse, Treasuries are priced for a pretty
quiet few weeks. There is a little bit of election uncertainty
priced into this market, but I think the reality is, because of
all the uncertainties around the vote and the possibility of a
difficult transition, it has really kept a lot of people highly
focused on the topic, but not necessarily with high
convictions," said Hill.

A slew of investment-grade corporate bond deals came to
market on Monday, which may also have contributed to slower
demand for U.S. government debt. Just under $4 billion in new
high-grade corporate paper had been priced by mid-afternoon
Monday, with a three-part $2 billion deal from Pernod Ricard
still expected to come.

"Positioning on credit may have a little bit of influence on
rates. We’ve got a decent amount of new issue credit deals this
week ahead of the start of earnings season. Positioning ahead of
the credit supply probably is having an influence in the rates
market as well" said Guy LeBas, chief fixed income strategist at
Janney Montgomery Scott.
(Reporting by Kate Duguid; editing by Jonathan Oatis and David
Gregorio)

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.